Fureasu Co.,Ltd. (7062.T)
JPY 970.0
(0.21%)
JPY 970.0
(0.21%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 172.02 Million | -233.14 Million | 309.27 Million | -99.96 Million | -99.72 Million |
| Net Income | 123.57 Million | 89.58 Million | 258.43 Million | 112.08 Million | 56.87 Million |
| Depreciation & Amortization | 156.83 Million | 97.37 Million | 67.5 Million | 53.54 Million | 18.5 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -259.09 Million | -227.31 Million | 23.98 Million | -227.07 Million | -35.49 Million |
| Other non-cash items | 95.76 Million | -86.35 Million | -5.22 Million | -121.98 Million | -78.21 Million |
| Investing Cash Flow | -193.6 Million | -516.91 Million | -149.46 Million | -296.83 Million | -193.33 Million |
| Investments in PPE | -130.11 Million | -83.93 Million | -142.89 Million | -18.82 Million | -8 Million |
| Acquisitions | -9.09 Million | -393.74 Million | 16.81 Million | -278.25 Million | -179.37 Million |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -54.4 Million | -39.23 Million | -19.69 Million | 241 Thousand | -5.95 Million |
| Financing Cash Flow | 177.12 Million | 511.11 Million | -160.97 Million | 464.34 Million | 82.12 Million |
| Debt repayment | -221.9 Million | -541.27 Million | -163.96 Million | -462.83 Million | -42.7 Million |
| Dividends payments | -24.81 Million | -21.73 Million | - | - | - |
| Common Stock Repurchased | - | - | -70 Thousand | - | - |
| Common Stock Issuance | - | 7.59 Million | 3.06 Million | 1.51 Million | 124.83 Million |
| Other Financing Activities | -2000.00 | -1000.00 | 3 Million | 2 Million | -1000.00 |
| Accounts receivables | -50 Million | -203 Million | -57 Million | 104 Million | -19.17 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -3.85 Million | -2.99 Million | 420 Thousand | -2.44 Million | -5.23 Million |
| Other working capital | -189 Million | -184 Million | 37 Million | -476 Million | -11.08 Million |
| Cash at beginning of period | 975.26 Million | 1.21 Billion | 1.21 Billion | 1.14 Billion | 1.35 Billion |
| Cash at end of period | 1.13 Billion | 975.26 Million | 1.21 Billion | 1.21 Billion | 1.14 Billion |
| Capital Expenditure | -130.11 Million | -83.93 Million | -142.89 Million | -18.82 Million | -8 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 155.55 Million | -238.94 Million | -1.17 Million | 67.54 Million | -210.93 Million |
| Free Cash Flow | 41.91 Million | -317.07 Million | 166.37 Million | -118.78 Million | -107.73 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56 Million | 8 Million | 123.57 Million | 31 Million | -10 Million | 29 Million |
| Depreciation & Amortization | - | - | 156.83 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -259.09 Million | - | - | - |
| Other non-cash items | 56 Million | -8 Million | 95.76 Million | -31 Million | 10 Million | -29 Million |
| Investing Cash Flow | - | - | -193.6 Million | - | - | - |
| Investments in PPE | - | - | -130.11 Million | - | - | - |
| Acquisitions | - | - | -9.09 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -54.4 Million | - | - | - |
| Financing Cash Flow | - | - | 177.12 Million | - | - | - |
| Debt repayment | - | - | -221.9 Million | - | - | - |
| Dividends payments | - | - | -24.81 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -2000.00 | - | - | - |
| Accounts receivables | - | - | -50 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -3.85 Million | - | - | - |
| Other working capital | - | - | -189 Million | - | - | - |
| Cash at beginning of period | - | - | 975.26 Million | - | - | - |
| Cash at end of period | - | - | 1.13 Billion | - | - | - |
| Capital Expenditure | - | - | -130.11 Million | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 155.55 Million | - | - | - |
| Free Cash Flow | - | - | 41.91 Million | - | - | - |
7115
XGN
RKKE
AMS
ODMUF
BIOX